Cargando…

Vaccine-Associated Enhanced Disease and Pathogenic Human Coronaviruses

Vaccine-associated enhanced disease (VAED) is a difficult phenomenon to define and can be confused with vaccine failure. Using studies on respiratory syncytial virus (RSV) vaccination and dengue virus infection, we highlight known and theoretical mechanisms of VAED, including antibody-dependent enha...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gartlan, Cillian, Tipton, Tom, Salguero, Francisco J., Sattentau, Quentin, Gorringe, Andrew, Carroll, Miles W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9014240/ https://www.ncbi.nlm.nih.gov/pubmed/35444667 http://dx.doi.org/10.3389/fimmu.2022.882972

Ejemplares similares

Efferocytosis of Pathogen-Infected Cells
por: Karaji, Niloofar, et al.
Publicado: (2017)

Viral Evasion of the Complement System and Its Importance for Vaccines and Therapeutics
por: Mellors, Jack, et al.
Publicado: (2020)

Ebolavirus: Comparison of Survivor Immunology and Animal Models in the Search for a Correlate of Protection
por: Longet, Stephanie, et al.
Publicado: (2021)

Pre-clinical models to define correlates of protection for SARS-CoV-2
por: Brady, Caolann, et al.
Publicado: (2023)

Inflammasome-Mediated Immunogenicity of Clinical and Experimental Vaccine Adjuvants
por: Reinke, Sören, et al.
Publicado: (2020)

Complement-Mediated Neutralisation Identified in Ebola Virus Disease Survivor Plasma: Implications for Protection and Pathogenesis
por: Mellors, Jack, et al.
Publicado: (2022)

Regulatory T-Cells at the Interface between Human Host and Pathogens in Infectious Diseases and Vaccination
por: Boer, Mardi C., et al.
Publicado: (2015)

Influence of Aerosol Delivered BCG Vaccination on Immunological and Disease Parameters Following SARS-CoV-2 Challenge in Rhesus Macaques
por: White, Andrew D., et al.
Publicado: (2022)

Sterile inflammation induced by Carbopol elicits robust adaptive immune responses in the absence of pathogen-associated molecular patterns
por: Gartlan, Kate H., et al.
Publicado: (2016)

Envelope Glycoprotein Trimers as HIV-1 Vaccine Immunogens
por: Sattentau, Quentin J.
Publicado: (2013)

Immunogenicity and Protective Efficacy of Seasonal Human Live Attenuated Cold-Adapted Influenza Virus Vaccine in Pigs
por: Holzer, Barbara, et al.
Publicado: (2019)

Commentary: Origin and evolution of pathogenic coronaviruses
por: Adachi, Shun, et al.
Publicado: (2020)

mRNA vaccination drives differential mucosal neutralizing antibody profiles in naïve and SARS-CoV-2 previously-infected individuals
por: Longet, Stephanie, et al.
Publicado: (2022)

Adjuvants for Coronavirus Vaccines
por: Liang, Zhihui, et al.
Publicado: (2020)

New templates for HIV-1 antibody-based vaccine design
por: Sattentau, Quentin J, et al.
Publicado: (2010)

Herd Immunity to Ebolaviruses Is Not a Realistic Target for Current Vaccination Strategies
por: Masterson, Stuart G., et al.
Publicado: (2018)

The Carbomer-Lecithin Adjuvant Adjuplex Has Potent Immunoactivating Properties and Elicits Protective Adaptive Immunity against Influenza Virus Challenge in Mice
por: Wegmann, Frank, et al.
Publicado: (2015)

Development of prophylactic vaccines against HIV-1
por: Schiffner, Torben, et al.
Publicado: (2013)

Stabilized HIV-1 envelope glycoprotein trimers for vaccine use
por: Medina-Ramírez, Max, et al.
Publicado: (2017)

Vaccine Hesitancy and Rejection of a Vaccine for the Novel Coronavirus in the United States
por: Shih, Shu-Fang, et al.
Publicado: (2021)

COVID-19: Coronavirus Vaccine Development Updates
por: Zhao, Jing, et al.
Publicado: (2020)

Dynamics of Macrophage, T and B Cell Infiltration Within Pulmonary Granulomas Induced by Mycobacterium tuberculosis in Two Non-Human Primate Models of Aerosol Infection
por: Hunter, Laura, et al.
Publicado: (2022)

Innate Immune Responses to Highly Pathogenic Coronaviruses and Other Significant Respiratory Viral Infections
por: Ahmed-Hassan, Hanaa, et al.
Publicado: (2020)

MTBVAC: Attenuating the Human Pathogen of Tuberculosis (TB) Toward a Promising Vaccine against the TB Epidemic
por: Gonzalo-Asensio, Jesus, et al.
Publicado: (2017)

Potential Cross-Reactive Immunity to SARS-CoV-2 From Common Human Pathogens and Vaccines
por: Reche, Pedro A.
Publicado: (2020)

Nasal Immunization Confers High Avidity Neutralizing Antibody Response and Immunity to Primary and Recurrent Genital Herpes in Guinea Pigs
por: Persson, Josefine, et al.
Publicado: (2016)

The Capricious Nature of Bacterial Pathogens: Phasevarions and Vaccine Development
por: Tan, Aimee, et al.
Publicado: (2016)

Subunit Vaccines Against Emerging Pathogenic Human Coronaviruses
por: Wang, Ning, et al.
Publicado: (2020)

The Mucosal and Serological Immune Responses to the Novel Coronavirus (SARS-CoV-2) Vaccines
por: Chan, Renee W. Y., et al.
Publicado: (2021)

Editorial: Innovative Therapeutic and Vaccine Approaches Against Respiratory Pathogens
por: Calzas, Cynthia, et al.
Publicado: (2019)

Antibody-Based HIV-1 Vaccines: Recent Developments and Future Directions: A summary report from a Global HIV Vaccine Enterprise Working Group
por: Montefiori, David, et al.
Publicado: (2007)

A platform technology for generating subunit vaccines against diverse viral pathogens
por: Young, Andrew, et al.
Publicado: (2022)

Pre-existing humoral immunity to low pathogenic human coronaviruses exhibits limited cross-reactive antibodies response against SARS-CoV-2 in children
por: Li, Nina, et al.
Publicado: (2022)

Propionibacterium acnes Enhances the Immunogenicity of HIVBr18 Human Immunodeficiency Virus-1 Vaccine
por: Teixeira, Daniela, et al.
Publicado: (2018)

Potential Challenges for Coronavirus (SARS-CoV-2) Vaccines Under Trial
por: Usmani, Salman Sadullah, et al.
Publicado: (2020)

COVID-19 Coronavirus Vaccine Design Using Reverse Vaccinology and Machine Learning
por: Ong, Edison, et al.
Publicado: (2020)

Potential of conserved antigenic sites in development of universal SARS-like coronavirus vaccines
por: Wang, Siling, et al.
Publicado: (2022)

Effect of seasonal coronavirus immune imprinting on the immunogenicity of inactivated COVID-19 vaccination
por: Yin, Di, et al.
Publicado: (2023)

Addressing Parental Vaccine Hesitancy and Other Barriers to Childhood/Adolescent Vaccination Uptake During the Coronavirus (COVID-19) Pandemic
por: Olusanya, Olufunto A., et al.
Publicado: (2021)

Spore-FP1 tuberculosis mucosal vaccine candidate is highly protective in guinea pigs but fails to improve on BCG-conferred protection in non-human primates
por: White, Andrew D., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_2gemaaf1da80flhorvkuqoiui5